{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:59Z","timestamp":1787070839182,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.4103\/tjo.tjo-d-24-00046","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T06:00:09Z","timestamp":1718949609000},"page":"141-142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Getting a clearer picture of myopia after the COVID-19 pandemic"],"prefix":"10.4103","volume":"14","author":[{"given":"David A.","family":"Mackey","sequence":"first","affiliation":[{"name":"Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1186\/s12889-023-16719-z","article-title":"Effects of school myopia management measures on myopia onset and progression among Chinese primary school students","volume":"23","author":"Shi","year":"2023","journal-title":"BMC Public Health"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"100923","DOI":"10.1016\/j.preteyeres.2020.100923","article-title":"Efficacy in myopia control","volume":"83","author":"Brennan","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R3-20240830","article-title":"Childhood myopia and the COVID-19 pandemic:Lessons for future pandemics (in press)","author":"Au","year":"2024","journal-title":"Taiwan J Ophthalmol"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"e234080","DOI":"10.1001\/jamanetworkopen.2023.4080","article-title":"Prevalence of myopia in children before, during, and after COVID-19 restrictions in Hong Kong","volume":"6","author":"Zhang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R5-20240830","article-title":"Impact of the COVID-19 pandemic on the progression, prevalence and incidence of myopia:A systematic review (in press)","author":"Jonathan","year":"2024","journal-title":"Taiwan J Ophthalmol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/08820538.2023.2168490","article-title":"Myopia progression during the COVID-19 era:A systematic review and meta-analysis","volume":"38","author":"Najafzadeh","year":"2023","journal-title":"Semin Ophthalmol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13063-023-07277-1","article-title":"Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries","volume":"24","author":"McDonald","year":"2023","journal-title":"Trials"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","article-title":"Low-dose 0.01% atropine eyedrops versus placebo for myopia control:A randomized clinical trial","volume":"141","author":"Repka","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/aos.15761","article-title":"Myopia outcome study of atropine in children:Two-year result of daily 0.01% atropine in a European population","volume":"102","author":"Loughman","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"R10-20240830","first-page":"1","article-title":"Myopia progression following 0.01% atropine cessation in Australian children:Findings from the Western Australia \u2013Atropine for the Treatment of Myopia (WA-ATOM) study","author":"Lee","journal-title":"Clin Exp Ophthalmol 2024."},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ceo.14148","article-title":"Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children:A randomised clinical trial","volume":"50","author":"Lee","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41588-018-0127-7","article-title":"Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error","volume":"50","author":"Tedja","year":"2018","journal-title":"Nat Genet"},{"key":"R13-20240830","doi-asserted-by":"crossref","DOI":"10.4103\/tjo.TJO-D-24-00031","article-title":"The impact of light properties on ocular growth and myopia development:A review (in press)","author":"Chen","year":"2024","journal-title":"Taiwan J Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:26Z","timestamp":1787067446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00046","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2024-04-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}